Tricuspid Valve Insufficiency Clinical Trial
— Contour3DOfficial title:
Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial
Verified date | May 2017 |
Source | Medtronic Cardiovascular |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.
Status | Completed |
Enrollment | 64 |
Est. completion date | June 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Subject or legal guardian willing and able to sign and date the Informed Consent Form (and Authorization to Use and Disclose Health Information Form, if applicable) - Subject indicated for a concomitant surgical repair of the TV - Subject is willing to return for required follow-up visits to the hospital where the implantation originally occurred Exclusion Criteria: - Subject with a degenerative TV condition - Subject with primary TV regurgitation - Subject with a previous TV repair or replacement - Subject indicated for a stand-alone TV repair - Subject currently participating in an investigational drug or another device study - Subject with life expectancy of less than one year - Subject is pregnant or desires to be pregnant within 12 months following implantation - Subject is under 18 or over 85 years of age - Subject with active endocarditis - Subject with valvular retraction with severely reduced mobility - Subject with a heavily calcified TV |
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan | Ann Arbor | Michigan |
United States | Mission Hospital Research Institute | Asheville | North Carolina |
United States | Florida Heart & Vascular Care at Aventura | Aventura | Florida |
Lead Sponsor | Collaborator |
---|---|
Medtronic Cardiovascular |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in the Degree of Tricuspid Regurgitation | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment. Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant. |
Preimplant through Discharge | |
Primary | Change in the Degree of Tricuspid Regurgitation | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment. Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant. |
Preimplant through 6 Months | |
Primary | Change in the Degree of Tricuspid Regurgitation | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment. Degree of TV regurgitation - Change in the degree of tricuspid regurgitation from preimplant through 12 months postimplant. |
Preimplant through 12 Months | |
Primary | The Mean Gradient Across the Tricuspid Valve | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the mean gradient across the tricuspid valve. The mean gradient across the tricuspid valve measured at discharge, 6 months, and 12 months post-implant | Discharge | |
Primary | The Mean Gradient Across the Tricuspid Valve | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the mean gradient across the tricuspid valve. The mean gradient across the tricuspid valve measured at discharge, 6 months, and 12 months post-implant | 6 months | |
Primary | The Mean Gradient Across the Tricuspid Valve | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the mean gradient across the tricuspid valve. The mean gradient across the tricuspid valve measured at discharge, 6 months, and 12 months post-implant | 12 months | |
Primary | Change in the Degree of TV Leaflet Coaptation Length | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet coaptation length. Change in the degree of TV leaflet coaptation length from preimplant through 12 months postimplant. | Preimplant through Discharge | |
Primary | Change in the Degree of TV Leaflet Coaptation Length | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet coaptation length. Change in the degree of TV leaflet coaptation length from preimplant through 12 months postimplant. | Preimplant through 6 Months | |
Primary | Change in the Degree of TV Leaflet Coaptation Length | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet coaptation length. Change in the degree of TV leaflet coaptation length from preimplant through 12 months postimplant. | Preimplant through 12 Months | |
Primary | Change in the Degree of TV Leaflet Tethering Height | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet tethering height. Change in the degree of TV leaflet tethering height from pre-implant through 12 months post-implant. | Preimplant through Discharge | |
Primary | Change in the Degree of TV Leaflet Tethering Height | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet tethering height. Change in the degree of TV leaflet tethering height from pre-implant through 12 months post-implant. | Preimplant through 6 Months | |
Primary | Change in the Degree of TV Leaflet Tethering Height | The primary objective is the evaluation of hemodynamic performance of the TV postimplant of a tricuspid annuloplasty ring in a postmarket environment by analysis of the TV leaflet tethering height. Change in the degree of TV leaflet tethering height from pre-implant through 12 months post-implant | Preimplant through 12 Months | |
Secondary | Change in the Right Ventricle (RV) Diastolic Area | The secondary objective is the evaluation of effect of TV repair with the study ring on Right ventricle (RV) diastolic area at end diastole. Change in the Right ventricle (RV) diastolic area from preimplant through 12 months post-implant. | Preimplant through Discharge | |
Secondary | Change in the Right Ventricle (RV) Diastolic Area | The secondary objective is the evaluation of effect of TV repair with the study ring on Right ventricle (RV) diastolic area at end diastole. Change in the Right ventricle (RV) diastolic area from preimplant through 12 months post-implant. | Preimplant through 6 Months | |
Secondary | Change in the Right Ventricle (RV) Diastolic Area | The secondary objective is the evaluation of effect of TV repair with the study ring on Right ventricle (RV) diastolic area at end diastole. Change in the Right ventricle (RV) diastolic area from preimplant through 12 months post-implant | Preimplant through 12 Months | |
Secondary | Change in the Tricuspid Annular (Basal) Diameter | The secondary objective is the evaluation of effect of TV repair with the study ring on Tricuspid annular (basal) diameter. Change in the tricuspid annular (basal) diameter from preimplant through 12 months post-implant | Preimplant through Discharge | |
Secondary | Change in the Tricuspid Annular (Basal) Diameter | The secondary objective is the evaluation of effect of TV repair with the study ring on Tricuspid annular (basal) diameter. Change in the tricuspid annular (basal) diameter from preimplant through 12 months post-implant | Preimplant through 6 Months | |
Secondary | Change in the Tricuspid Annular (Basal) Diameter | The secondary objective is the evaluation of effect of TV repair with the study ring on Tricuspid annular (basal) diameter. Change in the tricuspid annular (basal) diameter from preimplant through 12 months post-implant | Preimplant through 12 Months | |
Secondary | Change in the RV Fractional Area | The secondary objective is the evaluation of effect of TV repair with the study ring on RV fractional area. Change in the RV fractional area preimplant through 12 months post-implant. | Preimplant through Discharge | |
Secondary | Change in the RV Fractional Area | The secondary objective is the evaluation of effect of TV repair with the study ring on RV fractional area. Change in the RV fractional area preimplant through 12 months post-implant. | Preimplant through 6 Months | |
Secondary | Change in the RV Fractional Area | The secondary objective is the evaluation of effect of TV repair with the study ring on RV fractional area. Change in the RV fractional area preimplant through 12 months post-implant. | Preimplant through 12 Months | |
Secondary | Demographic Data | Characterize the patient population for which an annuloplasty ring is chosen to repair TV insufficiency and assess the effect of TV repair with the study ring on the tricuspid valve functional status | Baseline | |
Secondary | Change in New York Heart Association (NYHA) Classification | Assess the effect of TV repair with the study ring on the tricuspid valve functional status by analysis of the New York Heart Association (NYHA) classification from pre-implant through 12 months post-implant. | Preimplant through Discharge | |
Secondary | Change in New York Heart Association (NYHA) Classification | Assess the effect of TV repair with the study ring on the tricuspid valve functional status by analysis of the New York Heart Association (NYHA) classification from pre-implant through 12 months post-implant. | Preimplant through 6 months | |
Secondary | Change in New York Heart Association (NYHA) Classification . | Assess the effect of TV repair with the study ring on the tricuspid valve functional status by analysis of the New York Heart Association (NYHA) classification from pre-implant through 12 months post-implant. | Preimplant through 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06196684 -
Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
|
||
Not yet recruiting |
NCT03278418 -
Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach
|
N/A | |
Terminated |
NCT03632967 -
Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System
|
N/A | |
Active, not recruiting |
NCT05724225 -
"Atriogenic Tricuspid Selected, Omics Profile, Multimodality Imaging and Clinical Outcomes"
|
||
Completed |
NCT02981953 -
TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System
|
N/A | |
Completed |
NCT01444222 -
Behaviour of Tricuspid Valve Regurgitation in Volume and/or Pressure Loaded Right Heart
|
||
Recruiting |
NCT04653428 -
German Registry for Transcatheter Tricuspid Valve Interventions
|
||
Recruiting |
NCT02574650 -
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
|
N/A | |
Completed |
NCT04945005 -
Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation Registry
|
||
Recruiting |
NCT03225612 -
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
|
N/A | |
Withdrawn |
NCT03166488 -
MRE Evaluation of Liver Stiffness After Tricuspid Valvular Repair
|
N/A | |
Completed |
NCT03604484 -
Prophylactic Tricuspid Annuloplasty During Mitral Valve Surgery
|
N/A | |
Completed |
NCT01537458 -
Long-term Outcome After Isolated Tricuspid Valve Repair
|
||
Recruiting |
NCT05913908 -
EFS of the DUO System for Tricuspid Regurgitation (TANDEM II)
|
N/A | |
Recruiting |
NCT04436653 -
THE TRAVEL TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve
|
N/A | |
Completed |
NCT01334801 -
Biomarkers in Aortic Stenosis - B.A.S.S.
|
||
Recruiting |
NCT04735003 -
Transcatheter Interventions for Tricuspid Insufficiency in Italy
|
||
Recruiting |
NCT02314897 -
Left Ventricular Pacing to Prevent Iatrogenic TR Pilot Study
|
N/A | |
Completed |
NCT01532921 -
EASE TRICUSPID Expertise-based Assessment Study on Clinical Efficacy of Contour 3D® in TRICUSPID Valve Annuloplasty
|
||
Active, not recruiting |
NCT04614402 -
Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System
|